Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals.

Authors	Nicolas Penel, Thomas Ryckewaert, Diane Pannier
Journal	Cancer (Cancer) Vol. 126 Issue 20 Pg. 4614-4615 (10 15 2020) ISSN: 1097-0142 [Electronic] United States
PMID	32767671 (Publication Type: Letter, Comment)
Chemical References	Dacarbazine Doxorubicin Ifosfamide
Topics	Antineoplastic Combined Chemotherapy Protocols Dacarbazine (therapeutic use) Doxorubicin (therapeutic use) Humans Ifosfamide (adverse effects) Leiomyosarcoma (drug therapy) Propensity Score Sarcoma (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!